DalsnaFinance › IPOs › Dermata Therapeutics › IPO
Dermata Therapeutics, Inc. completed its initial public offering on NASDAQ on August 13, 2021, pricing at $7.00 a share.
| Ticker | DRMA |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | August 13, 2021 |
| Offering price | $7.00 |
| Shares offered | 2,571,428 |
| Total raised | $18M |
Dermata Therapeutics, Inc. sold 2,571,428 shares at $7.00 each on NASDAQ. Multiplied out, that is $18 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $18 million total recorded for the deal.
Dermata Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Dermata Therapeutics, Inc.. This page is general information, not investment advice.